Dr. Mathias is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12605 E 16th Ave
Aurora, CO 80045Phone+1 720-848-0000
Education & Training
- University of ColoradoFellowship, Surgical Retina and Vitreous, 2012 - 2014
- University of ColoradoResidency, Ophthalmology, 2009 - 2012
- Ohio State University HospitalInternship, Internal Medicine, 2008 - 2009
- Ohio State University College of MedicineClass of 2008
Certifications & Licensure
- CO State Medical License 2012 - 2025
- OH State Medical License 2008 - 2010
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- 4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP) Start of enrollment: 2020 Jun 09
Publications & Presentations
PubMed
- 3 citationsInterleukin-4 Plasma Levels Stratified by Sex in Intermediate Age-Related Macular Degeneration and Geographic Atrophy.Vivian Rajeswaren, Brandie D Wagner, Jennifer L Patnaik, Naresh Mandava, Marc T Mathias
Translational Vision Science & Technology. 2023-08-01 - 31 citationsSystemic activation of the complement system in patients with advanced age-related macular degeneration.Anne M. Lynch, Naresh Mandava, Jennifer L. Patnaik, Ashley Frazer-Abel, Brandie D. Wagner
European Journal of Ophthalmology. 2020-09-01 - 19 citationsComplement factors and reticular pseudodrusen in intermediate age-related macular degeneration staged by multimodal imaging.Anne M. Lynch, Alan G. Palestine, Brandie D. Wagner, Jennifer L. Patnaik, Ashley A Frazier-Abel
BMJ Open Ophthalmology. 2020-01-01
Press Mentions
- 4D Molecular Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial of 4D-125 by Intravitreal Injection for the Treatment of X-linked Retinitis PigmentosaAugust 19th, 2020
- University of Colorado Ophthalmologists Administer Novel Treatment for Single Patient Facing Rare Genetic ConditionSeptember 7th, 2023
- Mini-Retinas Model Human Disease in a DishJuly 18th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: